The doxycycline paradox in primary mitochondrial diseases

J Inherit Metab Dis. 2022 Jul;45(4):659-660. doi: 10.1002/jimd.12531. Epub 2022 Jul 5.

Authors

Tamas Kozicz^{1

2}, Shamima Rahman³, Eva Morava^{1

2}

Affiliations

¹ Department of Clinical Genomics, Mayo Clinic, Rochester, Minnesota, USA.
² University of Pécs Medical School, Pécs, Hungary.
³ Mitochondrial Research Group, UCL Great Ormond Street Institute of Child Health, and Metabolic Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

PMID: 35734980
DOI: 10.1002/jimd.12531

No abstract available

Publication types

Editorial

MeSH terms

Doxycycline* / therapeutic use
Humans
Mitochondria
Mitochondrial Diseases* / drug therapy

Substances

Doxycycline